FDA Device Recalls

Recalls /

#183013

Product

The OEC 9900 C-Arm is designed to provide fluoroscopic and spot-film images of the patient during diagnostic, surgical and interventional procedures. Examples of clinical application may include cholangiography, endoscopy, urologic, orthopedic, neurologic, vascular, cardiac, critical-care and emergency room procedures. The GE OEC 9800 is designed to provide fluoroscopic and spot-film imaging of the patient during diagnostic, surgical and interventional procedures. The system includes features specifically designed for use in diagnostic and interventional cardiac imaging procedures, and is also intended for cholangiography, endoscopic, urologic, orthopedic, neurologic, vascular, critical care and emergency room procedures.

FDA product code
RCCC-Arm Fluoroscopic X-Ray System
Device class
Class 2
Medical specialty
Radiology
510(k) numbers
K111551, K120613, K122234, K132027
Affected lot / code info
OEC 9800, OEC 9900 Elite

Why it was recalled

GEHC Surgery became aware that some users of the 9800 and 9900 fluoroscopic mobile C-Arms (referred to as the system here on) within the United States had requested that a Field Service Engineer (FSE) change the dose value on the live update screen from AKR / CAK to DAP. All systems sold to customers in the US that leave GEHC Surgery (the place of manufacture) are configured to display AKR / CAK when they leave the factory. An FSE changing the dose display, per the customer request, to display DAP instead does not comply to 21CFR 1020.32(k), which requires fluoroscopic equipment manufactured on or after June 10, 2006 to display continuous updates of AKR and CAK values.

Root cause (FDA determination)

Radiation Control for Health and Safety Act

Recalling firm

Firm
Ge Healthcare
Address
384 Wright Brothers Dr, Salt Lake City, Utah 84116-2862

Distribution

Distribution pattern
Nationwide

Timeline

Recall initiated
2020-05-08
Posted by FDA
2020-08-27
Status

Source: openFDA Device Recall endpoint. Recall record ID #183013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.